Beijing Aosaikang Pharmaceutical Co Ltd
002755
Company Profile
Business description
Beijing Aosaikang Pharmaceutical Co Ltd is engaged in the research and development of domestic high-end first imitation drugs, chemical drugs, and biological drugs. Its products focus on digestion, tumors, drug-resistant infections, and chronic diseases.
Contact
South Fourth Ring Road
Building 28 , 7th District, No. 188
Fengtai District
Beijing100070
CHNT: +86 1063706999
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
988
Stocks News & Analysis
stocks
PayPal earnings: Growth slows, new CEO appointed
We expect to lower our fair value estimate of PayPal stock.
stocks
Morningstar initiates on ASX income play
This REIT may be an option for investors seeking income.
stocks
What Goodman’s upcoming earnings could reveal about data centre & AI growth
Answering key questions about Goodman & its data centre pipeline ahead of earnings
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,142.90 | 5.20 | -0.06% |
| CAC 40 | 8,179.50 | 1.67 | -0.02% |
| DAX 40 | 24,780.79 | 16.73 | -0.07% |
| Dow JONES (US) | 49,197.49 | 210.17 | -0.43% |
| FTSE 100 | 10,314.59 | 26.97 | -0.26% |
| HKSE | 26,834.77 | 59.20 | 0.22% |
| NASDAQ | 23,255.19 | 336.92 | -1.43% |
| Nikkei 225 | 54,289.23 | 431.43 | -0.79% |
| NZX 50 Index | 13,391.90 | 20.54 | -0.15% |
| S&P 500 | 6,904.93 | 71.51 | -1.03% |
| S&P/ASX 200 | 8,860.50 | 8.20 | 0.09% |
| SSE Composite Index | 4,067.70 | 0.04 | -0.00% |